Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism

Shexiang Baoxin Pill (SBP) originated from a classical TCM Fufang Suhexiang Pill for chest pain with dyspnea in the Southern Song Dynasty (1107–110 AD). Here, we aimed to evaluate preclinical evidence and possible mechanism of SBP for experimental coronary heart disease (CHD). Studies of SBP in anim...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ke-Jian, Zhu, Jia-Zhen, Bao, Xiao-Yi, Zheng, Qun, Zheng, Guo-qing, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487520/
https://www.ncbi.nlm.nih.gov/pubmed/28701954
http://dx.doi.org/10.3389/fphar.2017.00404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487520/
https://www.ncbi.nlm.nih.gov/pubmed/28701954
http://dx.doi.org/10.3389/fphar.2017.00404

Ejemplares similares